Track topics on Twitter Track topics that are important to you
Silver sulfadiazine is an antibacterial drug used for making personal care products. Silver sulfadiazine is listed as the essential medicines by World Health Organization and is widely used as an antibiotic for treating second and third degree burn wounds on the skin. Silver sulfadiazine also helps in preventing the growth of bacteria and yeast on the skin. Silver sulfadiazine is also commonly used to treat urinary tract infections UTIs. Sulfadiazine, when combined with pyrimethamine, is used for curing the disease Toxoplasmosis. The healing capacity of silver sulfadiazine has been questioned over and again by various researchers and numerous research studies. Despite varied market opinions; silver sulfadiazine remains to be one of the most popular medicines for treatment on burns as it's is considered to be a powerful medication for burn wounds. Additionally, silver sulfadiazine is used in majority of the hospitals in North America as it is considered the most powerful treatment for burns. Globally increasing incidences of the burn injuries and increasing adoption in developing nations is expected drive the global demand for Silver sulfadiazine during the period of study.
Silver Sulfadiazine Market
Geographically North America dominated silver sulfadiazine market driven by best in the class healthcare infrastructure, advanced facilities, higher awareness, higher technological penetration and higher spending by the citizens towards healthcare expenditure. North America was followed by Europe and AsiaPacific as second and third largest market for silver sulfadiazine market. Asia Pacific is projected to have fastest growth, owing to rapidly increasing healthcare infrastructure, increased spending, government initiatives and increasing awareness amongst population, and growing medical tourism industry in developing nations such as China, and India in this region.
This report identifies the global silver sulfadiazine market size in for the year 20142016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global silver sulfadiazine market.
This report segments global silver sulfadiazine market on the basis of application and regional market as follows:
Silver Sulfadiazine Market research report is classified on the basis of application. Some of the major applications of silver sulfadiazine covered in this report are as follows: Wound Care, Burn Care, Skin Care, Urinary Tract Infections UTIs
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, AsiaPacific APAC, and Rest of the World RoW covering all the major country level markets in each of the region
This report identifies all the major companies operating in the silver sulfadiazine market. Some of the major companies' profiles in detail are as follows:
Johnson Johnson Limited
Baxter International Inc
Teva Pharmaceutical Industries Ltd.
Original Article: Silver Sulfadiazine Market: By Application Wound Care, Burn Care, Skin Care, UTIs By Geography Europe, Asia Pacific, North America, Rest of the WorldForecast 20162021 [Updated: 06092016] Prices from USD $5250NEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...